SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001493152-24-024237
Filing Date
2024-06-18
Accepted
2024-06-18 13:36:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 form425.htm 425 40133
2 ex10-3.htm EX-10.3 27204
  Complete submission text file 0001493152-24-024237.txt   69014
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
TenX Keane Acquisition (Filed by) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
TenX Keane Acquisition (Subject) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-41534 | Film No.: 241050914
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)